PepGen Inc (PEPG) - Uzoq muddatli majburiyatlarning kapitalga nisbati
PepGen Inc. miopatiyalarni davolash uchun oligonukleotid terapiyalarini ishlab chiqishda yuqori ilmiy mavqega ega. Uzoq muddatli qarzdorlikning kapitalga nisbati qarz dinamikasini aks ettiradi, bunda 0.12 qiymati joriy ko'rsatkichni ifodalaydi. Daromad potentsiali Dyushenn mushak distrofiyasi uchun RNA terapiyasining sug'urta to'lovlariga asoslangan, ammo sotuvlar yo'qligi sababli kapitalizatsiya faqat kelajakdagi patentlarga bog'liq.
&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_PEPG_-_PepGen-Inc._-_Long-Term-Debt-to-Equity-Ratio "PEPG - PepGen Corp Uzoq muddatli qarzning kapitalga nisbati 28.04.2023 - 29.10.2026 oraligʻida | 👁️GURU.Markets👁️")
PepGen Inc. kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati PepGen Inc.|PEPG - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati PepGen Corp|PEPG - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar PepGen Inc.|PEPG - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar PepGen|Kritik likvidlik pepgen.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:PEPG (pepgen.com)
PepGen Inc. geosiyosiy beqarorlik va ta'minot zanjiridagi uzilishlar sharoitida nevromuskulyar patologiyalarni davolash uchun innovatsion dori vositalarini ishlab chiqadi. Uzoq muddatli qarzdorlikning kapitalga nisbati uzoq davom etadigan klinik sinovlar davridagi kompaniyaning moliyaviy barqarorligini miqdoriy baholaydi. Ushbu ko'rsatkich kapital tuzilmasidagi uzoq muddatli kreditlarning ulushini o'lchab, retsessiya davrlarida defolt xavfini aniqlaydi. Past qiymatlar yashab qolishni kafolatlaydi, ammo o'sish sur'atlarini cheklashi mumkin. Uzoq muddatli qarzdorlikning kapitalga nisbatini tahlil qilish orqali investor emitentning haqiqiy qarz yukini baholaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|harmonybiosciences.com - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BHVN|AMLX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|PRAX (Praxis Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati ceribell.com (CBLL)|PRTA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Alector (ALEC)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annexon Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMER (Omeros Corp.)|Uzoq muddatli qarzning o'z kapitaliga nisbati NGNE (Neurogene Inc.)|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati Neumora (NMRA)|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|TVGN (Tevogen Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ACOG: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati cogrx.com|Uzoq muddatli qarzning o'z kapitaliga nisbati IKT|Cassava Sciences Inc (SAVA) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Ovid Therapeutics Inc (OVID) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati CRVO|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Clene CLNN|Uzoq muddatli qarzning o'z kapitaliga nisbati Jupiter Neurosciences Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi RLMD (relmada.com)|Uzoq muddatli qarzning kapitalga nisbati ANVS|GRCE - Uzoq muddatli majburiyatlarning kapitalga nisbati|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ANEW Medical KLTO|NRSN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti RVPH (revivapharma.com)|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati NeurAxis Inc. (NRXS)|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Passage Bio Corp - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati NEUP|NERV - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|ADXN (Addex Therapeutics Ltd.) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Alzamend - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Cyclerion Therapeutics (CYCN)|PTIX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Cortigent Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (Brainstorm Cell Therapeutics, Inc.)|CARA (Cara Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati Eliem Therapeutics, Inc. (ELYM)|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH (Longboard Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|MRNS: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NKGen Biotech Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati NRBO|sagerx.com (SAGE) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati VIGL (Vigil Neuroscience, Inc.)|Anew Medical Inc. (WENA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CERE - Uzoq muddatli qarzning o'z kapitaliga nisbati